PRRT2 and kidney disorder: Studies on the molecular mechanisms of PKC activation in renal disease indicate that activation of PKC signaling, enhanced polyol signaling, increased oxidative stress, and overproduction of advanced glycation end products lead to hyperglycemia and promote diabetic vascular complications [277,278].